TTY Biopharm Company Limited (TPEX:4105)
Taiwan · Delayed Price · Currency is TWD 75.50
-0.30 (-0.40%)
Aug 12, 2025, 1:30 PM CST
Satixfy Communications Market Cap
TTY Biopharm Company has a market cap or net worth of 18.85 billion as of August 11, 2025. Its market cap has decreased by -0.92% in one year.
Market Cap
18.85B
Enterprise Value
18.80B
Revenue
6.22B
Ranking
n/a
PE Ratio
11.94
Stock Price
$75.50
Market Cap Chart
Since July 3, 2003, TTY Biopharm Company's market cap has increased from 3.05B to 18.85B, an increase of 518.13%. That is a compound annual growth rate of 8.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2025 | 18.85B | 4.12% |
| Dec 31, 2024 | 18.10B | -9.45% |
| Dec 29, 2023 | 19.99B | -3.60% |
| Dec 30, 2022 | 20.74B | 21.22% |
| Dec 30, 2021 | 17.11B | 0.29% |
| Dec 31, 2020 | 17.06B | -16.75% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 203.18B |
| PharmaEssentia | 166.30B |
| Bora Pharmaceuticals Co., LTD. | 88.86B |
| Lotus Pharmaceutical | 56.28B |
| Oneness Biotech | 30.90B |
| Polaris Group | 27.31B |
| Center Laboratories | 26.39B |
| Pegavision | 24.38B |